http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104056247-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate | 2013-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104056247-B |
| titleOfInvention | A kind of pharmaceutical composition and preparation thereof containing hepatocyte growth-promoting factors |
| abstract | The invention belongs to medical art, the invention provides a kind of pharmaceutical composition and the preparation thereof that contain hepatocyte growth-promoting factors, pharmaceutical composition contains hepatocyte growth-promoting factors, glutathion; Wherein hepatocyte growth-promoting factors 5-15 weight portion in pharmaceutical composition, glutathion 0.05-0.1 weight portion.The method that pharmaceutical composition of the present invention is combined by stability test and pharmacology test, is obtained by screening.Test shows, pharmaceutical preparation prepared by pharmaceutical composition of the present invention, has more outstanding product quality. |
| priorityDate | 2013-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.